CFW |
CFW-AN145900U |
10mg-1g |
咨询 |
937174-76-0 |
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-... GSK690693 |
分析标准品 |
咨询
|
请联系客服购买!
|
罗恩 |
R032709-1mg |
1mg |
现货 |
937174-76-0 |
土大黄甙 GSK690693 |
99% |
175.00
175.00
|
|
毕得 |
BD234847-5mg |
5mg |
现货 |
937174-76-0 |
(S)-4-(2-(4-氨基-1,2,5-额二唑-3-基... (S)-4-(2-(4-Amino-1,2,5-oxad... |
98+% |
415.00
415.00
|
|
毕得 |
BD234847-10mg |
10mg |
现货 |
937174-76-0 |
(S)-4-(2-(4-氨基-1,2,5-额二唑-3-基... (S)-4-(2-(4-Amino-1,2,5-oxad... |
98+% |
704.00
704.00
|
|
毕得 |
BD234847-50mg |
50mg |
现货 |
937174-76-0 |
(S)-4-(2-(4-氨基-1,2,5-额二唑-3-基... (S)-4-(2-(4-Amino-1,2,5-oxad... |
98+% |
1,914.00
1,914.00
|
|
毕得 |
BD234847-100mg |
100mg |
现货 |
937174-76-0 |
(S)-4-(2-(4-氨基-1,2,5-额二唑-3-基... (S)-4-(2-(4-Amino-1,2,5-oxad... |
98+% |
3,062.00
3,062.00
|
|
毕得 |
BD234847-1mg |
1mg |
现货 |
937174-76-0 |
(S)-4-(2-(4-氨基-1,2,5-额二唑-3-基... (S)-4-(2-(4-Amino-1,2,5-oxad... |
98+% |
139.00
139.00
|
|
毕得 |
BD234847-25mg |
25mg |
现货 |
937174-76-0 |
(S)-4-(2-(4-氨基-1,2,5-额二唑-3-基... (S)-4-(2-(4-Amino-1,2,5-oxad... |
98+% |
1,197.00
1,197.00
|
|
阿拉丁 |
G127527-10mg |
10mg |
现货 |
937174-76-0 |
GSK690693,新型ATP竞争性泛Akt激酶抑制剂 GSK-690693 |
≥98% |
1,029.90
1,029.90
|
|
阿拉丁 |
G127527-50mg |
50mg |
现货 |
937174-76-0 |
GSK690693,新型ATP竞争性泛Akt激酶抑制剂 GSK-690693 |
≥98% |
3,448.90
3,448.90
|
|
阿拉丁 |
G127527-5mg |
5mg |
现货 |
937174-76-0 |
GSK690693,新型ATP竞争性泛Akt激酶抑制剂 GSK-690693 |
≥98% |
617.90
617.90
|
|
阿拉丁 |
G127527-100mg |
100mg |
现货 |
937174-76-0 |
GSK690693,新型ATP竞争性泛Akt激酶抑制剂 GSK-690693 |
≥98% |
5,767.90
5,767.90
|
|
阿拉丁 |
G409035-1ml |
1ml |
现货 |
937174-76-0 |
GSK690693 GSK690693 |
10mM in DMSO |
808.90
808.90
|
|